Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 16571-852

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 16571-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-label-14mg.jpg (Memantine Label 14mg)

Label for Memantine Hydrochloride Extended-Release Capsules, 14 mg, by Rising Pharma Holdings, Inc. The label indicates the product is a prescription oral capsule with 30 capsules per container. It includes dosage strength, manufacturer details, and storage instructions.*

FDA Label Image

Memantine-label-21mg.jpg (Memantine Label 21mg)

Label for Memantine Hydrochloride Extended-Release Capsules 21 mg, oral capsules, once daily, containing 30 capsules. Manufactured by Unique Pharmaceutical Laboratories, India, and labeled for Rising Pharma Holdings, Inc. The label includes storage instructions, dosage note, and child-resistant container warning.*

FDA Label Image

Memantine-label-28mg.jpg (Memantine Label 28mg)

Label for Memantine Hydrochloride Extended-Release Capsules 28 mg by Rising Pharma Holdings, Inc., containing 30 capsules. The label states the dosage form as extended-release capsules, strength as 28 mg, and indicates oral route with 'once daily' usage. It includes instructions to keep medication out of children's reach and storage conditions. Manufactured by Unique Pharmaceutical Laboratories in Mumbai, India.*

FDA Label Image

Memantine-label-7mg.jpg (Memantine Label 7mg)

Memantine Hydrochloride Extended-Release Capsules 7 mg, oral dosage form, with a 30-capsule count. The label shows the product name, strength, and indicates it is for prescription use only. It is manufactured by Unique Pharmaceutical Laboratories in India and labeled for Rising Pharma Holdings, Inc. The label includes storage and handling instructions.*

FDA Label Image

Memantine-struct.jpg (Memantine Struct)

Chemical structure of memantine hydrochloride, showing the bicyclic amine structure with two methyl groups and an amino group, alongside the hydrochloride (HCl) component.*

FDA Label Image

Memantine01.jpg (Memantine01)

Line graph comparing the mean change from baseline in SIB score over 24 weeks of treatment for Memantine Hydrochloride Extended-Release Capsules 28 mg and placebo. The x-axis shows weeks of treatment from 0 to 24, and the y-axis shows the change in SIB score indicating clinical improvement or decline. Memantine shows greater improvement over time compared to placebo.*

FDA Label Image

Memantine02.jpg (Memantine02)

A cumulative percentage plot showing the distribution of SIB (Severe Impairment Battery) score changes from baseline in patients. The graph compares Memantine Hydrochloride extended-release capsules with placebo, each in combination with AChEI. The x-axis represents SIB change from baseline, and the y-axis shows the cumulative percentage of patients.*

FDA Label Image

Memantine03.jpg (Memantine03)

Line graph depicting mean CIBIC-Plus scores with standard error bars over 24 weeks of treatment, comparing Memantine Hydrochloride Extended-Release Capsules 28 mg to placebo, both alongside AChEI. The y-axis ranges from 3.6 to 4.4 (lower scores indicate clinical improvement, higher clinical decline), and the x-axis represents weeks of treatment from 0 to 24.*

FDA Label Image

Memantine04.jpg (Memantine04)

A bar graph comparing the effects of Memantine Hydrochloride Extended-Release Capsules 28 mg versus placebo on patient outcomes. The x-axis shows CIBIC Plus Rating categories ranging from marked improvement to marked worsening. The y-axis represents the percentage of patients. The graph displays percentage distributions for each rating category in both treatment and placebo groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.